State-of-the-art facility designed to support medical research, learning and entrepreneurshipContinue reading
Author Archive: AZBio
Caris Life Sciences Raises $830 Million in Growth Equity Capital to Continue to Expand its Precision Medicine Platform
Caris Life Sciences Raises $830 Million in Growth Equity Capital to Continue to Expand its Precision Medicine Platform
Accelerates Caris’ rapid growth as the market leader reshaping precision oncology through basic science research and the application of artificial intelligence to one of the largest clinico-genomic databases
Capital raise represents one of the largest private financings in precision medicine supported by a diverse, high-quality syndicate of leading investorsContinue reading
Castle Biosciences Supports the American Skin Association with Research Grant
The ASA Castle Biosciences Research Grant Melanoma was awarded to Joel Sunshine, M.D., Ph.D., Johns Hopkins School of Medicine
Rays of Hope Conference Brings Brain Injury Survivors Together
Rays of Hope provides an annual opportunity for survivors, their families, and caregivers to share experiences on their respective roads to recovery. This emotional connection often leads to greater insights about the invisible disability known as brain injury.Continue reading
CSL Behring Announces Closing of Global Commercialization and License Agreement with uniQure for etranacogene dezaparvovec
• Etranacogene dezaparvovec (AMT-061) is an investigational gene therapy that may potentially provide people with hemophilia B with years of functional levels of Factor IX, a blood-clotting protein that prevents excessive bleeding.
• uniQure will complete the Phase 3 HOPE-B trial and scale up manufacture for initial commercial supply under an agreed plan with CSL Behring.
Arizona Expands Telehealth Law, Making it Broadest in the Nation
On May 5, 2021, Governor Ducey signed H.B. 2454, legislation which dramatically expands access to telehealth services in Arizona. The legislation—the most expansive in the country—makes telemedicine a permanent fixture of Arizona’s healthcare system.Continue reading
Pfizer and BioNTech Receive First U.S. Authorization for Emergency Use of COVID-19 Vaccine in Adolescents
- In a Phase 3 trial, the vaccine was 100% effective and generally well tolerated in participants aged 12 to 15 years
- Data also submitted to European Medicines Agency (EMA) and other global regulators, with additional authorizations expected in coming weeks
Clouds Over the Capitol
TRIPS Waiver, MCIT, HR3. If you are not familiar with these policy developments, you probably should be.
The United States medtech and biotech industries make a tremendous impact on people’s lives. When policy makers and Federal Agencies work together, the impact is made even greater. However, some policy decisions can have the opposite effect.
BIO Extends Agreement with Avantor
Collaboration has evolved for more than two decades
BD Announces Intent to Spin Off Diabetes Care Business to Enhance Focus on Innovation and Priority Growth Markets
Standalone Diabetes Care business expected to leverage position as global leader in insulin delivery and expand presence in large and high-growth diabetes marketContinue reading